22 Nov

Results of Meeting

BCAL Diagnostics Limited ABN 51 142 051 223 Suite 506 Level 5 50 Clarence Street Sydney NSW. 2000 PO Box Q128 Queen Victoria Building NSW 1230 22 November 2021 Results of Annual General Meeting BCAL Diagnostics Limited (ASX:BDX) (‘BCAL’ or ‘Company’) today held its Annual General Meeting (AGM) as a virtual online event. All resolutions were determined by a poll. The outcome of each resolution put to shareholders at the Annual General Meeting is set out in the Annexure which accompanies this release. This announcement has been approved by Guy Robertson, Company Secretary of BCAL Diagnostics Limited. ENDS Contact for more information: Guy Robertson Company Secretary E grobertson@bcaldiagnostics.com M +61 407 983 270 BCAL DIAGNOSTICS LIMITED 2021 Annual General Meeting Monday, 22 November 2021 Results of Meeting The following information is provided in accordance with section 251AA(2) of the Corporations Act 2001 (Cth) and ASX Listing Rule 3.13.2. Resolution Resul t Resolution Resolution T yp e For Against Proxy's Discretion Abstain Carried / Not Carried 36,104,210 11,125 0 0 76,142,108 8,000 8,260,604 0 Resolution details Instructions given to validly appointed proxies (as at proxy close) 1. Resolution 1: Adoption of remuneration report Ordinary Carried 2. Resolution 2: Re-election of Director, Ronald Phillips Ordinary Carried
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from BCAL Diagnostics Limited (ASX:BDX) when you join Listcorp.